Features of syndrome X develop in transgenic rats expressing a non- insulin responsive phosphoenolpyruvate carboxykinase gene

Diabetologia

Volumn 42, Issue 4, 1999, Pages 419-426

  Thorburn, A W ^a,b   Baldwin, M E ^a   Rosella, G ^a   Zajac, J D ^a   Fabris, S ^a   Song, S ^a   Proietto, J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Cholesterol; Glucose; Insulin; Insulin resistance; Obesity; Phosphoenolpyruvate carboxykinase; Syndrome X; Transgenic rats; Triglycerides

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); TRIACYLGLYCEROL;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; GENETIC ENGINEERING; GLUCONEOGENESIS; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULIN RESPONSE; LIPID DIET; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; RAT; SYNDROME X; TRANSGENIC ANIMAL; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INSULIN; INSULIN RESISTANCE; MALE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RATS; TRIGLYCERIDES;

EID: 0033015491     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051174     Document Type: Article

References (36)

1. Reaven G (1988) Role of insulin resistance in human disease. Diabetes 37: 1595-1607
2. Kaplan NM (1989) The deadly quartet. Upper body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 149: 1514-1520
3. Pickup JC, Mattock MB, Chusney GD, Burt D (1997) NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40: 1286-1292
4. Ferrannini E, Haffner SM, Mitchell BD, Stern MP (1991) Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34: 416-422
5. Harris M, Hadden W, Knowler W, Bennett P (1987) Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U. S. population aged 20-74 years. Diabetes 36: 523-534
6. Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16: 434-444
7. Mayer EJ, Newman B, Austin MA et al. (1996) Genetic and environmental influences on insulin levels and the Insulin Resistance Syndrome: an analysis of women twins. Am J Epidemiol 143: 323-332
8. Mitchell BD, Kammerer CM, Mahaney MC et al. (1996) Genetic analysis of the IRS. Pleiotrophic effects of genes influencing insulin levels on lipoprotein and obesity measures. Arterioscler Thromb Vase Biol 16: 281-288
9. Baillie GM, Sherer JT, Weart CW (1998) Insulin and coronary artery disease: is syndrome X the unifying hypothesis? Ann Pharmacother 32: 233-247
10. Salonen JT, Lakka TA, Lakka HM, Valkonen VP, Everson SA, Kaplan GA (1998) Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men. Diabetes 47: 270-275
11. DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15: 318-368
12. Cusin I, Terrettaz J, Rohner-Jeanrenaud F, Jeanrenaud B (1990) Metabolic consequences of hyperinsulinemia imposed on normal rats on glucose handling by white adipose tissue, muscles and liver. Biochem J 267: 99-103
13. Ferrannini E (1992) The insulin resistance syndrome. Curr Opin Nephrol Hypertens 1: 291-298
14. Barnard RJ, Roberts CK, Varon SM, Berger JJ (1998) Diet-induced insulin resistance precedes other aspects of the metabolic syndrome. J Appl Physiol 84: 1311-1315
15. Phillips DI (1998) Birth weight and the future development of diabetes. A review of the evidence. Diabetes Care 21 [Suppl 2]: B 150-155
16. Storlien LH, Baur LA, Kriketos AD et al. (1996) Dietary fats and insulin action. Diabetologia 39: 621-631
17. McClain DA, Crook ED (1996) Hexosamines and insulin resistance. Diabetes 45: 1003-1009
18. Wahrenberg H, Lonnqvist F, Arner P (1989) Mechanisms underlying regional differences in lipolysis in human adipose tissue. J Clin Invest 84: 458-67
19. Jenkins AB, Storlien LH, Chisholm DJ, Kraegen EW (1988) Effects of nonesterified fatty acid availability on tissue-specific glucose utilization in rats in vivo. J Clin Invest 82: 293-299
20. Boden G, Chen X, Rosner J, Barton M (1995) Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 44: 1239-1242
21. Andrikopoulos S, Rosella G, Kaczmarczyk S, Zajac J, Proietto J (1996) Impaired regulation of hepatic fructose-1,6-bisphosphatase in the New Zealand Obese mouse: An acquired defect. Metabolism 45: 622-626
22. Rosella G, Zajac JD, Baker L et al. (1995) Impaired glucose tolerance and increased weight gain in transgenic rats overexpressing a non-insulin responsive phosphoenolpyruvate carboxykinase gene. Mol Endocrinol 9: 1396-1404
23. Dickens RA, Rosella G, Zajac J, Proietto J (1997) Insulin inhibits gluconeogenesis predominantly through suppression of phosphoenolpyruvate carboxykinase. Diabetologia 40: A 24
24. Allain C, Poon L, Chan C, Richmond W, Fu P (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20: 470-475
25. Megraw R, Dunn D, Biggs H (1979) Manual and continuous-flow colorimetry of triacylglycerols by a fully enzymic method. Clin Chem 25: 273-278
26. Abe H, Yamada N, Kamata K et al. (1998) Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J Clin Invest 101: 1784-1788
27. Ludwig DS, Vidal-Puig A, O'Brien RM et al. (1996) Examination of the phosphoenolpyruvate carboxykinase gene promoter in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81: 503-506
28. Ossei-Gerning N, Mansfield MW, Stickland MH, Grant PJ (1997) Insulin receptor substrate-1 gene polymorphism and cardiovascular risk in non-insulin dependent diabetes mellitus and patients undergoing coronary angiography. Clin Lab Haematol 19: 123-128
29. Sacks D, McDonald J (1996) The pathogenesis of Type II diabetes mellitus - a polygenic disease. Am J Clin Pathol 105: 149-156
30. Bjorntorp P (1994) Abdominal obesity and the metabolic syndrome. Ann Med 24: 465-468
31. Despres JP (1993) Abdominal obesity as an important component of insulin-resistance syndrome. Nutrition 9: 452-459
32. Steiner G (1994) Hyperinsulinemia and hypertriglyceridaemia. J Intern Med 236 [Suppl 736]: 23-26
33. Maheux P, Azhar S, Kern PA, Chen YD, Reaven GM (1997) Relationship between insulin-mediated glucose disposal and regulation of plasma and adipose tissue lipoprotein lipase. Diabetologia 40: 850-858
34. DeFronzo R, Ferrannini E (1991) Insulin resistance - a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194
35. Friedman JE, Ishizuka T, Liu S et al. (1997) Reduced insulin receptor signalling in the obese spontaneously hypertensive Koletsky rat. Am J Physiol 273: E1014-E1023
36. Iwase M, Yamamoto M, Iino K et al. (1998) Obesity induced by neonatal monosodium glutamate treatment in spontaneously hypertensive rats: an animal model of multiple risk factors. Hypertens Res 21: 1-6